Digitisation | April 10, 2026
Beacon raises $132M+ to bring AI-driven sleep diagnostics to masses
The device aims to bring precision neuroscience into clinical trials, accelerating drug development
The device aims to bring precision neuroscience into clinical trials, accelerating drug development
The dual expansion simplifies transcriptomics workflows by combining faster regional turnaround with easier sample logistics
The JADE trial enrolled 164 U.S. patients who initially received three monthly doses of OLN324 or faricimab, followed by 12 weeks off treatment with retreatment allowed only if disease recurred
Government outlines advanced shared infrastructure and DBT-ICGEB biofoundry expansion to fast-track lab-to-market innovation across six strategic biotech sectors
The move represents a significant milestone in Lupin’s strategy to expand its specialty care portfolio and strengthen its presence in Europe
The milestone moves the company closer to its previously announced $120 million US expansion, with groundbreaking slated for late 2026
The collaboration highlights the rising importance of intranasal delivery in developing non-vaccine approaches to respiratory disease prevention
COVIRIX Medical says its broad-spectrum antiviral portfolio has already shown positive virology results against key pandemic threats
Cevimeline Hydrochloride Capsules 30mg are indicated for the symptomatic treatment of dry mouth (xerostomia) associated with Sjögren’s syndrome.
The first of four planned modules at the new plant is expected to come online by summer 2026
Subscribe To Our Newsletter & Stay Updated
